Sahajanand Medical Technologies IPO Day 2: Check GMP, subscription status
Benchmarks Nifty22,997.35374.65FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.69 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.78 % Invest NowEnter search…
Sahajanand Medical Technologies IPO entered Day 2 on October 16, 2026, with a 12% GMP and 34% subscription on Day 1. The Rs 475.48-crore offer for sale is priced at Rs 327-344 per share. PAT surged 175% to Rs 69 crore in FY26 amid steady revenue growth.
Sahajanand Medical Technologies' initial public offering (IPO) entered its second day of bidding on October 16, 2026. The issue is commanding a grey market premium (GMP) of 12%, suggesting expectations of potential listing gains in the unofficial market. However, the GMP is subject to fluctuations and does not guarantee actual listing performance.On Day 1, the IPO was subscribed 34% overall against the 97.50 lakh shares on offer. The retail individual investor (RII) category saw 40% subscription against the 47.50 lakh shares reserved for retail investors.
The medical technology company aims to raise Rs 475.48 crore through the IPO, which comprises an offer for sale (OFS) of 1.38 crore shares. Since the issue is entirely an OFS, the company will not receive any proceeds from the offering, with the funds going to the selling shareholders.
Sahajanand Medical Technologies has fixed the IPO price band at Rs 327-344 per share. The issue will close on October 19, 2026, while the basis of allotment is expected to be finalised on October 21. The shares are tentatively scheduled to list on the BSE and NSE on October 23.
The IPO lot size is 43 shares, translating into a minimum investment of Rs 14,792 for retail investors applying at the upper end of the price band.
Live Events
Ahead of the public issue, Sahajanand Medical Technologies raised Rs 140 crore from anchor investors. The company allotted 40,71,634 equity shares at Rs 344 apiece, which is the upper end of the IPO price band.
Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities & Capital Markets (India) and Nuvama Wealth Management are the book-running lead managers for the issue, while MUFG Intime India has been appointed as the registrar.
On Day 1, Sahajanand Medical Technologies' IPO was subscribed 34% overall against the 97.50 lakh shares on offer.
- The retail individual investor (RII) category was subscribed 40% against the 47.50 lakh shares reserved for retail investors.
- The qualified institutional buyer (QIB) category was subscribed 37% against the 27.14 lakh shares reserved for this segment.
Sahajanand Medical Technologies IPO GMP Today
Sahajanand Medical Technologies' latest grey market premium (GMP) stands at Rs 41 per share, or around 12% above the upper end of the IPO price band of Rs 344. Based on the prevailing grey market premium, the estimated listing price is Rs 385 per share. However, GMP is an unofficial indicator and does not guarantee the actual listing price or returns.Financial Performance
Sahajanand Medical Technologies Ltd.'s total income increased 18% to Rs 1,219 crore in FY26 from Rs 1,036 crore in FY25. Profit after tax (PAT) surged 175% to Rs 69 crore in FY26, compared with Rs 25 crore in the previous financial year.About Sahajanand Medical Technologies Ltd.
Incorporated in October 2001, Sahajanand Medical Technologies Ltd. is a medical technology company engaged in developing, manufacturing and marketing advanced medical devices, primarily for vascular and structural heart interventions. Its product portfolio includes coronary stents, balloons, transcatheter aortic valve implantation (TAVI) devices, occluders, renal stents and peripheral drug-coated balloons. Its flagship brands include Supraflex Cruz, Cocoon and Hydra, supported by a focus on research, precision manufacturing and product innovation.The company operates three manufacturing facilities across India and Thailand, along with two research and development centres. As of June 30, 2026, it held 119 patents globally, with 78 patent applications in the pipeline, and marketed its products in 77 countries in FY26. Revenue from operations rose to Rs 1,210.50 crore in FY26 from Rs 1,024.88 crore in FY25 and Rs 901.60 crore in FY24. As of June 30, 2026, the company had 1,605 full-time employees, 31 consultants and 707 contract workers.
Disclaimer: The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our ETMarkets WhatsApp channel)
Read More News onsahajanand medical ipo gmpsahajanand medical ipo subscription statussahajanand medical ipo reviewsahajanand medical ipo detailssahajanand medical ipo price bandshould i buy sahajanand medical iposahajanand medical share pricenuvama wealth management
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
...moreless(You can now subscribe to our ETMarkets WhatsApp channel)
Read More News onsahajanand medical ipo gmpsahajanand medical ipo subscription statussahajanand medical ipo reviewsahajanand medical ipo detailssahajanand medical ipo price bandshould i buy sahajanand medical iposahajanand medical share pricenuvama wealth management
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
...morelessPrime ExclusivesInvestment IdeasStock Report PlusePaperWealth EditionUS mid-term elections – Part 2: What does it mean for Trump to lose control of Congress?
The ABCD of the US mid-term elections – Part 1: Why it matters across the globe
Curbing rupee bets: What the RBI’s new rules mean for the hedge-now-or-wait question
Brinjal, buffalo, bacteria: Inside India’s pay-for-nature system
Homebuyers wait as NCLT panel picks holes in unfinished Jaypee projects
The NBFC saga - Part 3: How one default in 2018 changed the way RBI reads risk
- 1
- 2
- 3
& personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions &
in-depth stock reportsSubscribe NowET
Unlock Access to All Exclusives with ETPrime FREE TRIAL
15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers
Trial offer expiring in00 : 05 : 00
I'd rather pay ₹2599 nowUh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Prime Account Detected!
It seems like you're already an ETPrime member with
Login using your ET Prime credentials to enjoy all member benefits
Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.
Unlock ETPrime's Exclusive Stories Today!
Big Price Drop! Flat 40% Off
Student Only OfferAlready a Member? Sign In nowAlready a Member? Sign In nowAlready a Member? Sign In nowOffer Exclusively For You
Save up to Rs. 700/-
ON ET PRIME MEMBERSHIP
Avail OfferOffer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail OfferOffer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail OfferOffer Exclusively For You
Get Flat 40% Off
Then ₹ 1749 for 1 year
Avail OfferOffer Exclusively For You
ET Prime at ₹ 49 for 1 month
Then ₹ 1749 for 1 year
Avail OfferSpecial Offer
Get flat 40% off on ETPrime
Avail OfferAvail OfferClaim NowAlready a Member? Sign In nowNeed Assistance?
Connect with an ETPrime expert for personalized support and guidance
+91 9484700004'; }); } if(listing) { var h3 = "You tried reading " + listArr.length + " locked stories in the past " + threshold + " days.", h4 = "Become an ET Prime member and don't miss out on these exclusive stories."; var html = '' + h3 + '
' + h4 + '
- ' + listing + '
What’s Included with
ETPrime Membership
1Exclusive Insights That Matter
Uncover the truth with our investigative stories
Make strategic moves using the real-world case studies
Read industry-specific stories to identify emerging trends
Spot opportunities with in-depth insights that matter
Trump temper on H-1B visas is forcing Indians to do these things to stay put in US
What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.
Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?
The problem with lab grown diamonds
Why a falling rupee is a better option for the economy
A list of top 20 momentum stocks that have delivered massive returns in one year
2Invest Wisely With Smart Market Tools & Investment Ideas
Alpha Trade
Get daily trade ideas from SEBI-registered research analysts.
Investment Ideas
Grow your wealth with stock ideas & sectoral trends.
Stock Reports Plus
All-in-one stock research with Stock Score, peer comparison & key signals.
BigBull Portfolio
Get to know where the market bulls are investing to identify the right stocks.
Stock Analyzer
Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.
Market Mood
Analyze the market sentiments & identify the trend reversal for strategic decisions.
Stock Talk Live at 9 AM Daily
Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.
3Stay informed anytime, anywhere with ET ePaper
ePaper - Print View
Read the PDF version of ET newspaper. Download & access it offline anytime.
ePaper - Digital View
Read your daily newspaper in Digital View & get it delivered to your inbox everyday.
Wealth Edition
Manage your money efficiently with this weekly money management guide.
TOI ePaper
Read the PDF version of TOI newspaper. Download & access it offline anytime.
Deep Explainers
Explore the In-depth explanation of complex topics for everyday life decisions.
Health+ Stories
Get fitter with daily health insights committed to your well-being.
Personal Finance+ Stories
Manage your wealth better with in-depth insights & updates on finance.
5Enjoy Complimentary Subscriptions From Top Brands
Stream new documentaries from all across the world every day.
Stories you might be interested in
Figures reflect the source report and its stated period. This article is for information and is not investment advice.
